Ignite Creation Date:
2025-12-24 @ 11:35 PM
Ignite Modification Date:
2026-01-26 @ 8:39 AM
Study NCT ID:
NCT02120456
Status:
COMPLETED
Last Update Posted:
2025-03-06
First Post:
2014-04-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Escalating Doses of LEO 43204 Applied Once Daily for Two Consecutive Days on Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis
Sponsor:
LEO Pharma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-05
Start Date Type:
None
Primary Completion Date:
2015-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-05
Completion Date Type:
ACTUAL
First Submit Date:
2014-04-18
First Submit QC Date:
None
Study First Post Date:
2014-04-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-11-14
Results First Submit QC Date:
None
Results First Post Date:
2019-01-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2016-05-17
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2025-02-21
Last Update Post Date:
2025-03-06
Last Update Post Date Type:
ACTUAL